TNF Pharmaceuticals, Inc. (TNFA)
TNFA Stock Price Chart
Explore TNF Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze TNFA price movements and trends.
TNFA Company Profile
Discover essential business fundamentals and corporate details for TNF Pharmaceuticals, Inc. (TNFA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
23 Jan 2014
Employees
2.00
Website
https://tnfpharma.comCEO
Mitchell Glass
Description
TNF Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company. It focuses on developing two novel therapeutic platforms that treat the causes of disease rather than addressing the symptoms. Its MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. The MYMD-1 is being developed to delay aging, increase longevity, and treat autoimmune diseases. The company's second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction, and epilepsy. The Supera-CBD is a novel synthetic derivative of cannabidiol (CBD) and is being developed to address and improve the growing CBD market, which includes FDA approved drugs and CBD products not regulated as drugs. TNF Pharmaceuticals, Inc. was formerly known as MyMD Pharmaceuticals, Inc. and changed its name to TNF Pharmaceuticals, Inc. in July 2024. The company was founded in 2014 and is headquartered in Baltimore, Maryland.
TNFA Financial Timeline
Browse a chronological timeline of TNF Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 May 2026
Upcoming earnings on 12 Nov 2025
Stock split effective on 2 Sept 2025
Shares were split 1 : 100 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 19 Aug 2025
EPS came in at -$18.00 .
Earnings released on 15 May 2025
EPS came in at -$0.36 .
Earnings released on 11 Apr 2025
EPS came in at -$0.66 .
Earnings released on 14 Nov 2024
EPS came in at -$1.11 .
Earnings released on 19 Aug 2024
EPS came in at -$1.81 .
Earnings released on 15 May 2024
EPS came in at -$5.14 .
Earnings released on 31 Mar 2024
EPS came in at -$4.58 .
Stock split effective on 15 Feb 2024
Shares were split 1 : 30 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 30 Sept 2023
EPS came in at $2.70 .
Earnings released on 30 Jun 2023
EPS came in at -$3.10 .
Earnings released on 31 Mar 2023
EPS came in at -$1.14 .
Earnings released on 31 Dec 2022
EPS came in at -$2.85 .
Earnings released on 29 Sept 2022
EPS came in at -$2.84 .
Earnings released on 29 Jun 2022
EPS came in at -$2.85 .
Earnings released on 30 Mar 2022
EPS came in at -$3.24 .
Earnings released on 30 Dec 2021
EPS came in at -$2.58 .
Earnings released on 29 Sept 2021
EPS came in at -$4.36 .
Earnings released on 30 Jun 2021
EPS came in at -$15.12 .
Stock split effective on 19 Apr 2021
Shares were split 1 : 2 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 31 Mar 2021
EPS came in at -$2.50 .
Earnings released on 31 Dec 2020
EPS came in at -$37.39 .
Earnings released on 30 Sept 2020
EPS came in at -$2.52 .
TNFA Stock Performance
Access detailed TNFA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.